| (a) The Board shall promulgate specific guidelines
for dentists for the responsible prescribing of opioids, benzodiazepines,
barbiturates, or carisoprodol.
(b) The Board shall periodically access a dentist's
prescription information through the Prescription Monitoring Program
to determine whether they are engaging in potentially harmful prescribing
patterns or practices. This determination will be based on:
(1) the number of times a dentist prescribes opioids,
benzodiazepines, barbiturates, or carisoprodol; and
(2) patterns of prescribing combinations of those drugs
and other dangerous combinations identified by the Texas State Board
of Pharmacy.
(c) The Board shall notify a dentist if the agency
discovers that the dentist may be engaging in potentially harmful
prescribing patterns or practices.
(d) The Board may open a complaint against a dentist
if the agency finds evidence during a periodic check that the dentist
is engaging in conduct that violates any laws or rules related to
the practice of dentistry.
(e) This rule is effective on September 1, 2019, in
accordance with H.B. 2561 of the 85th Texas Legislature.
|
